Chemokines: structure, receptors and functions. A new target for inflammation and asthma therapy?
Five to 10% of the human population have a disorder of the respiratory tract called ‘asthma’. It has been known as a potentially dangerous disease for over 2000 years, as it was already described by Hippocrates and recognized as a disease entity by Egyptian and Hebrew physicians. At the beginning of...
Saved in:
| Main Authors: | F. A. A. van Acker, H-P. Voss, H. Timmerman |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
1996-01-01
|
| Series: | Mediators of Inflammation |
| Online Access: | http://dx.doi.org/10.1155/S0962935196000567 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting the chemokine receptor CXCR4 for cancer therapies
by: Ariana Rueda, et al.
Published: (2025-05-01) -
Progress in structure-based drug development targeting chemokine receptors
by: Jin Wang, et al.
Published: (2025-06-01) -
Chemokines and Chemokine Receptors in the Development of Lupus Nephritis
by: Xiaofeng Liao, et al.
Published: (2016-01-01) -
EXPRESSION OF mRNAS FOR CHEMOKINES AND CHEMOKINE RECEPTORS IN THE SKIN FROM PATIENTS WITH PSORIASIS
by: A. S. Beltiukova, et al.
Published: (2014-07-01) -
Biological targeted therapy for type 2 inflammation bronchial asthma
by: ZHANG Mingqiang, MU Xiangdong
Published: (2024-11-01)